Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ORC1 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | HCLS1 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
mRNA | LMNB1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | PROSER1 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | ARHGAP19 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
mRNA | GMEB1 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | MFNG | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |
mRNA | EXOSC8 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-12 |